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Type 1 diabetes (T1D) is an autoimmune dis-
ease  characterized  by  destruction  of  insulin-
producing  cells by T cells (Mathis et al., 2001). 
The development of T1D has been associated 
with defects in immunoregulation (Anderson 
and Bluestone, 2005). Restoration of efficient 
regulatory T  cell  (T  reg  cell)  populations  is 
therefore a promising therapeutic approach to 
prevent and even cure disease (Nishio et al., 
2010).  Studies  with  animal  models  have  re-
vealed the strong potential of two T reg cell 
subsets, Foxp3+ CD4+ T reg cells and NKT 
cells, in preventing T1D (Novak et al., 2007b; 
Tang and Bluestone, 2008). Invariant NKT cells 
(iNKT cells) are nonconventional T lympho-
cytes restricted by the CD1d molecule, which 
presents glycolipid antigens. These cells express 
a semi-invariant TCR comprising a canonical 
V14-J18 (V14) chain in the mouse and a 
V24-J18 chain in humans (Bendelac et al., 
2007). Many studies have shown the protective 
role of iNKT cells against the development of 
autoimmune diseases, including T1D (Van Kaer, 
2005). T1D can be prevented in nonobese dia-
betic (NOD) mice both by increasing iNKT 
cell numbers and by specific iNKT cell stimula-
tion with exogenous ligands such as -galactosyl-
ceramide  (-GalCer;  Lehuen  et  al.,  1998; 
Naumov et al., 2001; Sharif et al., 2001). Rela-
tive to control NOD mice, NOD mice pro-
tected from T1D by iNKT cell manipulation 
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Type 1 diabetes (T1D) is an autoimmune disease resulting from T cell–mediated destruction 
of insulin-producing  cells, and viral infections can prevent the onset of disease. Invariant 
natural killer T cells (iNKT cells) exert a regulatory role in T1D by inhibiting autoimmune  
T cell responses. As iNKT cell–plasmacytoid dendritic cell (pDC) cooperation controls viral 
replication in the pancreatic islets, we investigated whether this cellular cross talk could 
interfere with T1D development during viral infection. Using both virus-induced and spon-
taneous mouse models of T1D, we show that upon viral infection, iNKT cells induce TGF-–
producing pDCs in the pancreatic lymph nodes (LNs). These tolerogenic pDCs convert naive 
anti-islet T cells into Foxp3+ CD4+ regulatory T cells (T reg cells) in pancreatic LNs. T reg 
cells are then recruited into the pancreatic islets where they produce TGF-, which damp-
ens the activity of viral- and islet-specific CD8+ T cells, thereby preventing T1D develop-
ment in both T1D models. These findings reveal a crucial cooperation between iNKT cells, 
pDCs, and T reg cells for prevention of T1D by viral infection.
© 2011 Diana et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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increased frequency of CD4+ Foxp3+ T reg cells that produce 
TGF-. Importantly, TGF-–producing pDCs were critical 
for this iNKT cell–induced accumulation of T reg cells in the 
pancreatic islets through the conversion of naive T cells in the 
pancreatic LNs. Using both virally induced and spontaneous 
models of T1D, this study unveils a new bridge between in-
nate and adaptive immune responses in the prevention of auto-
immune disease after viral infection.
RESULTS
iNKT cells promote the accumulation of TGF-–producing  
T reg cells in pancreatic islets upon viral infection
Our previous study showed that in pancreatic islets, iNKT 
cells cooperate with pDCs to control viral replication, leading 
to a low effector anti-LCMV CD8+ T cell response. However, 
in the spleen, iNKT cells do not influence viral replication 
but promote an adaptive anti-LCMV CD8+ response (Diana 
et al., 2009). Because these effector T cells could migrate to 
peripheral tissues, including the pancreatic islets, we further 
analyzed the frequency and the effector functions of anti-
LCMV CD8+ T cells in the pancreatic islets. Although iNKT 
cells  dampened  the  IFN-  production  and  cytotoxicity 
(CD107a expression) of anti-NP396–404 CD8+ T cell responses, 
the frequency of tetramer+ staining anti-NP396–404 CD8+ T cells 
was similar in control, V14 mice, and -GalCer–treated Ins-
NP mice (Fig. S1, A–C). These observations suggested a role 
for regulatory mechanisms acting locally in the pancreatic 
islets. To address this possibility, we measured the frequency of 
Foxp3+ CD4+ T reg cells on various days after infection (Fig. 1 A 
and Fig. S2 A). Interestingly, the frequency of T reg cells in-
creased significantly in the pancreatic islets of control Ins-NP 
mice at day 11 after infection but not in the spleen and pan-
creatic LNs. The increase in pancreatic T reg cell frequency 
was significantly higher in V14 Ins-NP mice containing an 
elevated frequency of iNKT cells as well as in Ins-NP mice 
treated with the iNKT cell agonist -GalCer compared with 
control Ins-NP mice. In contrast, the frequency of T reg cells 
in the pancreatic islets of Cd1d/ Ins-NP mice, which lack 
iNKT cells, was not increased upon infection. The increase in 
T reg cell frequency was also observed in terms of absolute   
T cell numbers (Fig. S2 B). Of note, the newly described Foxp3+ 
iNKT cells (Monteiro et al., 2010) were not detected in any 
organs before or after LCMV infection (unpublished data).   
T reg cells exhibited a more activated phenotype in the pan-
creatic islets than in the lymphoid organs as shown by their 
higher expression of CD103 and CTLA-4 (Fig. S2 C). To 
further  explore  the  function  of T  reg  cells,  we  examined 
CD4+ T cell expression of TGF- (Fig. 1 B). Intracellular 
staining of CD4+ T cells 11 d after infection revealed that 
TGF- was significantly expressed in these T cells from pan-
creatic islets of Ins-NP control mice. In addition, the percent-
age of these TGF-+ T cells was much greater in V14 and 
-GalCer–treated Ins-NP mice. No increase in TGF- ex-
pression was seen in the spleen or pancreatic LNs of any of 
the mice. Using Foxp3-GFP Ins-NP mice, we confirmed that 
TGF- expression was restricted to Foxp3+ CD4+ T cells 
have weak anti-islet Th1 responses (Laloux et al., 2001). Indeed, 
iNKT cells can impair the differentiation of anti-islet CD4+ 
and CD8+ T cells, which eventually become hyporesponsive 
or anergic (Beaudoin et al., 2002; Chen et al., 2005a).
Converging epidemiological, genetic, and functional stud-
ies suggest that viral infections may play a role in T1D (Knip 
et al., 2005; Dotta et al., 2007; Nejentsev et al., 2009). Initial 
studies showed that various viruses could enhance or elicit 
T1D either by direct infection and destruction of target cells 
or by activating autoimmune T cell responses (Horwitz et al., 
1998; Roep et al., 2002; Filippi and von Herrath, 2008). How-
ever, virus can also prevent T1D onset (Oldstone, 1988; Tracy   
et al., 2002; Filippi et al., 2009). This is supported by signifi-
cant epidemiological data, as there is a concomitant decline in 
infections and increase in autoimmune diseases in Western 
countries (Viskari et al., 2005; Filippi and von Herrath, 2008; 
Tracy et al., 2010). The incidence of most autoimmune dis-
eases such as T1D, inflammatory bowel disease, and multiple 
sclerosis has been steadily increasing over the last three de-
cades in North America and Europe. Recently, it has been 
shown in experimental models using NOD mice that T reg 
cells are involved in the T1D protection by virus (Filippi et al., 
2009). However, the mechanism leading to T reg cell expan-
sion remains unknown.
Although iNKT cells inhibit autoimmune responses, they 
also promote immune responses against viruses (Tupin et al., 
2007; Diana and Lehuen, 2009). Upon activation, iNKT cells 
promptly secrete copious amounts of various cytokines, and 
they can provide activation/maturation signals to other im-
mune cells such as DCs, NK cells, T cells, and B cells. We re-
cently reported that during lymphochoriomeningitis virus 
(LCMV) infection, iNKT cells promote plasmacytoid DC 
(pDC) function locally in the pancreatic islets, leading to en-
hanced type I IFN production and low viral burden (Diana   
et al., 2009).
Because iNKT cell–pDC cooperation controls viral in-
fection in the pancreatic islets, we investigated the role of this 
cooperation in the development of T1D upon viral infection 
to determine whether both cell types could exert immuno-
regulatory functions in the pancreatic islets. To address this 
question, we used two mouse models: a transgenic model of 
virus-induced T1D, which expresses LCMV nucleoprotein in 
pancreatic  cells (Ins-NP) of NOD mice (Martinic et al., 
2007), and proinsulin 2/ (Ins2/) NOD mice, which is an 
accelerated model of spontaneous T1D (Thébault-Baumont 
et al., 2003). To analyze the influence of iNKT cells on diabe-
togenic CD8+ T cells, mice were either treated with an iNKT 
cell agonist or crossed to V14 transgenic (Lehuen et al., 
1998) or to Cd1d/ NOD mice (Mendiratta et al., 1997; 
Novak et al., 2007a), which are enriched or devoid of iNKT 
cells, respectively. Our results revealed that upon viral infec-
tion, iNKT cell–pDC interplay inhibited antiviral and anti-
islet diabetogenic CD8+ T cell responses in the pancreatic 
islets, thereby preventing both virus-induced and spontane-
ous T1D. This local inhibition of the autoimmune effector re-
sponses by iNKT cells after viral infection was caused by an JEM VOL. 208, April 11, 2011 
Article
731
mice and performed co-culture with splenic CD4+ CD25  
T responder cells (T resp cells) activated with anti-CD3/CD28 
beads (Fig. 2 A). Pancreatic T reg cells strongly inhibited naive   
T cell proliferation in vitro, and importantly, pancreatic T reg cells 
from V14 Ins-NP mice were more efficient than T reg cells 
from control Ins-NP mice. These data are in accordance with the 
higher production of TGF- detected in T reg cells from V14 
Ins-NP mice compared with control Ins-NP mice (Fig. 1 B).
(Fig. S2 D). Thus, our data suggest that upon viral infection, 
iNKT cells promote the accumulation of TGF-–producing 
T reg cells in the pancreatic islets.
T reg cells and TGF- inhibit pancreatic antiviral CD8+  
T cell responses and prevent T1D
To evaluate the suppressive activity of pancreatic T reg cells, we 
sorted them from infected Foxp3-GFP Ins-NP control or  V14 
Figure 1.  iNKT cells promote the accumulation of TGF-–producing T reg cells in the pancreatic islets upon viral infection. (A) Analysis 
of CD4+ Foxp3+ T cells after LCMV challenge of Ins-NP mice. Spleens and pancreatic LNs and islets were harvested on day 0 or 11 after infection. Cells 
were stained with anti-CD45, anti–TCR-, and anti-CD4 mAbs and then stained with anti-Foxp3 mAb for intracellular expression in the CD4+ TCR-+ 
population. (B) Analysis of TGF- expression by CD4+ T cells on days 0 and 11 after infection. Cells were stimulated with PMA-ionomycin over 6 h in 
the presence of brefeldin A and then surface stained with anti–TCR- and anti-CD4 mAbs and intracellularly stained with anti–TGF- mAb. Data are 
represented as mean values ± SD obtained in four independent experiments with three pooled mice for each group. *, P < 0.05 for day 11 mice com-
pared with day 0 mice.732 Prevention of T1D during viral infection | Diana et al.
diabetic, an incidence similar to that observed in untreated 
control Ins-NP mice (Table I). Using a viral dose of 104 PFU, 
all anti-CD25 mAb–treated control Ins-NP mice became dia-
betic as compared with 40–50% of untreated control mice. 
Similarly, blockade of TGF- reversed the protection medi-
ated by iNKT cells. Delayed treatment (day 9) with anti– 
TGF- mAb also efficiently abolished iNKT cell–mediated 
protection (unpublished data). Thus, iNKT cell–induced T reg 
cells and TGF- are required in the pancreatic islets to dampen 
the CD8+ T cell diabetogenic response and to prevent T1D.
iNKT cells promote the accumulation of pDCs in pancreatic 
LNs, which is critical for T reg cell accumulation  
in the pancreatic islets and the prevention of T1D
As pDCs can induce T reg cells in a noninfectious context 
(Ochando et al., 2006; Sharma et al., 2007; Hadeiba et al., 2008), 
To examine the role of T reg cells in the control of pan-
creatic anti-LCMV CD8+ T cell response,  V14 and -GalCer–
treated  Ins-NP  mice  were  treated  with  either  anti-CD25 
(Kohm et al., 2006) or anti–TGF- mAbs during LCMV in-
fection. The blockade of T reg cell function by these mAbs 
led to an increase in IFN-+ anti-NP396–404 CD8+ T cells in 
the pancreatic islets of V14 or -GalCer–treated Ins-NP mice 
both in terms of frequency and absolute number (Fig. 2 B, left 
and right, respectively). These mAb treatments did not in-
crease the already high frequency of IFN-+ anti-NP396–404 
CD8+ T cells in the pancreatic islets of control Ins-NP mice 
(unpublished data).
We next investigated whether T reg cells were involved in 
the iNKT cell–mediated protection against T1D. Anti-CD25 
mAb treatment abolished this protection, as around 80% of 
treated V14  or  -GalCer–treated  Ins-NP  mice  became   
Figure 2.  T reg cells and TGF- inhibit pancreatic antiviral CD8+ T cell response. (A) Proliferation of CD4+ CD25 T resp cells labeled with the 
cytosolic dye CFSE. In some wells, T reg cells sorted from the pancreatic islets of infected (day 11) Foxp3-GFP control or V14 Ins-NP mice were added at 
a ratio of 1 T reg cell/2 T resp cells. CFSE dilution in T resp cells cultured with or without T reg cells is presented as the percentage of undivided T resp 
cells. Data are represented as mean values ± SD obtained in three independent experiments with four pooled mice for each group. *, P < 0.05 for V14 
compared with control Ins-NP mice. (B) Analysis of NP396–404-specific CD8+ T cells upon LCMV infection of Ins-NP mice. 12 d after infection, pancreatic 
islets were harvested from mice treated with anti-CD25, anti–TGF-, or no mAb. After in vitro peptide stimulation, cells were stained with anti–TCR-  
and anti-CD8 mAbs and stained with anti–IFN- mAb for intracellular expression in the CD8+ TCR-+ population. Data are represented as mean values ± SD 
obtained in four independent experiments with three pooled mice for each group. *, P < 0.05 compared with untreated mice.JEM VOL. 208, April 11, 2011 
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Next,  we  examined  the  effect  of  pDC  depletion  and 
blockade of LN homing on T1D development (Table I). pDC 
depletion or LN homing blockade 4 d after infection com-
pletely abolished T1D protection in V14 or -GalCer–treated 
Ins-NP mice. Similarly, pDC depletion also increased T1D 
incidence in control Ins-NP mice infected with 104 PFU of 
LCMV. These results point to the critical role of pDCs and 
their migration to pancreatic LNs in the protective effect ex-
erted by iNKT cells against virus-induced diabetes.
pDCs produce TGF- in pancreatic LNs that converts naive 
T cells into T reg cells
Several  mechanisms  have  been  described  to  explain  how 
pDCs can induce T reg cells, including ICOS (inducible co-
stimulatory)–ICOS ligand molecular interaction, and in-
doleamine 2,3-dioxygenase (IDO) secretion (Ito et al., 2007; 
Sharma et al., 2007). We investigated the role of these path-
ways after LCMV infection. In our model, ICOS deficiency 
did not influence the pancreatic T reg cell frequency in 
LCMV-infected Ins-NP mice and did not abolish iNKT cell–
mediated T1D protection (Fig. S4, A and B). Blocking ICOS 
with a specific mAb (Herman et al., 2004) further ruled out 
the role of this pathway (unpublished data). We next evaluated 
the involvement of IDO by treating Ins-NP mice with its in-
hibitor, 1-methyl-d-tryptophan (1-MT;  Sharma et al., 2007). 
This treatment partially inhibited T1D prevention mediated 
by iNKT cells (Fig. S4, C and D). This was correlated with a 
slight decrease in the T reg cell frequency in the pancreatic is-
lets of infected  V14 and control Ins-NP mice; however, these 
decreases were not statistically significant.
Because TGF- is involved in T reg cell induction and 
expansion (Peng et al., 2004; Kretschmer et al., 2005), the role 
of this cytokine was explored using anti–TGF- mAb treat-
ment. TGF- blockade abolished the increased frequency of 
T reg cells in pancreatic islets of control, V14, and -GalCer–
treated Ins-NP mice after infection (Fig. 3 E). To determine 
whether pDCs could produce TGF- in pancreatic LNs after 
infection, its expression was evaluated by intracellular staining. 
we investigated whether pDCs were involved in the expan-
sion of pancreatic T reg cells after LCMV infection. Kinetics 
analysis of the pDC population showed that infection induced 
a rapid recruitment of pDCs to the pancreatic islets of control 
and V14 Ins-NP mice, with the pDC frequency reaching a 
maximum on day 2 and then progressively declining after 4 d 
(Fig. 3 A and Fig. S3 A). An increase in pDC frequency ap-
peared later in pancreatic LNs, peaking at day 6–8. In contrast, 
no increase in pDC frequency was observed in the pancreatic 
islets and LNs of Cd1d/ Ins-NP mice (Fig. 3, A–C). PDC 
frequency upon infection was higher in  V14 and -GalCer–
treated Ins-NP mice than in control Ins-NP mice (Fig. 3, A–C). 
Interestingly, 40% of pDCs in the pancreatic islets of V14   
Ins-NP mice on day 2 expressed high levels of CCR7 (Fig. 3 D) 
and CD62L (not depicted). The kinetics of increase in pDC 
frequency and the high expression of the CCR7 LN homing 
receptor suggest that pDCs first recruited to the pancreatic 
islets subsequently migrate to pancreatic LNs. An analysis of 
maturation markers (CD40, CD80, CD86, MHC class II, and 
PD-L1) on DC populations in pancreatic LNs revealed that 
both conventional DCs (cDCs) and pDCs were activated by 
day 6 after infection (Table II).
To assess the role of pDCs in T reg cell expansion, pDCs 
were depleted 4 d after infection with 120G8 mAb treatment 
(Fig. S3 B; Asselin-Paturel et al., 2003). Such depletion abro-
gated the increased frequency of pancreatic T reg cells nor-
mally observed after LCMV infection of control, V14, and 
-GalCer–treated Ins-NP mice (Fig. 3 E). To demonstrate the 
essential function of LN homing of pDCs in T reg cell devel-
opment and tolerance induction (Ochando et al., 2006), anti-
CD62L mAb treatment was performed 4 d after infection to 
block pDC homing to the LNs (Fig. S3 C). Such treatment 
prevented the increase in T reg cell frequency in the pancre-
atic islets (Fig. 3 E), thus confirming the critical role of LNs 
in the expansion of T reg cells in the pancreatic islets. Collec-
tively, these data suggest that upon LCMV infection, pDCs 
migrate from pancreatic islets to pancreatic LNs, which is 
critical for T reg cell accumulation in the pancreatic islets.
Table I.  Diabetes incidences after LCMV infection and various antibody treatments
Treatment Control V14 Control + -GalCer Control Cd1d/
105 PFU 105 PFU 105 PFU 104 PFU 104 PFU
None 10/12 0/12 1/12 6/12 12/12
Anti-CD25 12/12 11/12a 10/12a 12/12a ND
Control isotype 10/12 0/12 1/12 6/12 ND
Anti–TGF- 11/12 10/12a 10/12a 10/12a ND
Control isotype 10/12 0/12 0/12 7/12 ND
120G8 11/12 10/12a 10/12a 10/12a ND
Control isotype 10/12 0/12 1/12 6/12 ND
Anti-CD62L 10/12 11/12a 10/12a ND ND
Control isotype 10/12 1/12 0/12 ND ND
Incidence of T1D 20 d after LCMV infection with 104 or 105 PFU of Ins-NP mice treated with anti-CD25, anti–TGF-, 120G8, or anti-CD62L mAbs or with respective control 
isotype, as indicated. n = 12 for each group of mice.
aP-values <0.05 for mAb-treated mice compared with untreated mice.734 Prevention of T1D during viral infection | Diana et al.
4 d earlier (Fig. 4 A). 6 d later, IFN- production by BDC2.5 
T cells was analyzed. A similar frequency of IFN-+ BDC2.5 
T cells was observed in the pancreatic LNs of both mice.   
In contrast, the frequency of IFN-+ BDC2.5 T cells in the 
pancreatic islets was lower in V14 than in control Ins-NP 
mice. These data suggest that the suppression of the diabeto-
genic response occurs predominantly in the pancreatic islets.
We next investigated whether a cell conversion mecha-
nism was involved in pancreatic islet T reg cell accumulation 
upon LCMV infection. To address this question, sorted naive 
anti-islet BDC2.5 T cells devoid of T reg cells, isolated from 
The specificity of the staining was validated by showing that 
preincubation of the anti–TGF- mAb with recombinant 
TGF- abolished the staining (Fig. S3 D). 6 d after infection, 
25–30%  of  pDCs  in  the  pancreatic  LNs  of V14  or   
-GalCer–treated  Ins-NP  mice  produced TGF-  compared 
with 9% in control Ins-NP mice (Fig. 3 F). Only a low level 
of expression of TGF- was observed in pDCs from the pan-
creatic islets and the spleen. To determine whether TGF-–
producing pDCs in the pancreatic LNs could inhibit effector 
T cell function, anti-islet BDC2.5 T cells were transferred 
into V14 and control Ins-NP mice infected with LCMV   
Figure 3.  iNKT cells promote the accumulation of TGF-–producing pDCs in pancreatic LNs. (A–C) Analysis of pDC frequency in pancreatic 
LNs and islets of LCMV-infected Ins-NP mice. Cells were harvested at various times after infection and then stained with anti-CD45, anti-CD11c, and 
120G8 mAbs. Results represent the percentage of 120G8+ cells among total CD11c+ cells in A or among lymphoid-myeloid cells in B; absolute num-
bers at day 6 (C) of pDCs in the pancreatic LNs are shown. (D) Analysis of CCR7 expression on pDCs from pancreatic islets of V14 Ins-NP mice 2 d 
after infection. Cells were stained with anti-CD11c, 120G8, and anti-CCR7 mAbs. (E) Analysis of pancreatic T reg cell frequency after 120G8, anti-
CD62L mAb, or anti–TGF- mAb treatment in Ins-NP mice. Cells from pancreatic islets were harvested 11 d after infection and then stained with anti-
CD45, anti–TCR-, anti-CD4, and anti-Foxp3 mAbs. The dashed line indicates the frequency of Foxp3+ cells among CD4+ T cells in uninfected Ins-NP 
control mice. (F) Analysis of TGF- production by pDCs after LCMV infection. 6 d after infection, cells from spleen or pancreatic LNs or islets of Ins-NP 
mice were incubated for 5 h in the presence of brefeldin A and then stained with anti-CD11c and 120G8 mAbs and then intracellularly with anti–TGF-  
mAb. Data are represented as mean values ± SD obtained in four independent experiments, each performed with three pooled mice. *, P < 0.05  
compared with control mice (B, C, and F) or with untreated mice (E).JEM VOL. 208, April 11, 2011 
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Induction of tolerogenic pDCs by iNKT cells requires  
the IL-10 and PD-1–PD-L1 pathways
To investigate how pancreatic LN iNKT cells could induce 
TGF- production by pDCs, we characterized iNKT cell 
phenotype and function after LCMV infection. The frequency 
of iNKT cells detected in the pancreatic islets and LNs de-
creased at day 2 and 4, respectively (Fig. 5 A and Fig. S6 A).   
A similar decrease was also observed in terms of absolute 
number of iNKT cells (Fig. 5 B). The up-regulation of CD69 
and PD-1 and the down-regulation of NK1.1 expression in-
dicated the activation of iNKT cells in both organs (Fig. 5 C 
and Fig. S6, A and B). In terms of cytokine production, only 
a low frequency of IL-10–producing NKT cells was observed 
after infection (Fig. 5 D and Fig. S6 C). However, IL-10 ex-
pression was approximately sevenfold higher in terms of mean 
fluorescence intensity (MFI) in iNKT cells from the pancre-
atic LNs compared with iNKT cells from the pancreatic islets. 
iNKT cells were not anergic after LCMV infection, as their 
ability to produce IFN- and IL-4 was unchanged after   
-GalCer ex vivo stimulation (Fig. S6 D). Of note, the activa-
tion of iNKT cells in the pancreatic islets and LNs of infected 
mice required neither pDCs nor the CD1d molecule, as 
iNKT cells up-regulated CD69 even after pDC depletion   
or  in  mice  expressing  CD1d  exclusively  in  the  thymus   
(CD1dpLck mice; Fig. S7 A; Novak et al., 2007a).
To determine the molecular pathways involved in the in-
duction of TGF-–producing pDCs by iNKT cells, we co-
cultured  both  cell  types  sorted  from  the  spleen  or  the 
pancreatic LNs of 4-d infected V14 Ins-NP mice. 90 h later, 
TGF- released into the supernatant was measured by ELISA. 
TGF- was detected only when iNKT cells from the pancre-
atic LNs were added to the culture with pDCs from either 
the spleen or pancreatic LNs. TGF- production was higher 
with pDCs from pancreatic LNs. This result revealed the criti-
cal role of iNKT cells from the pancreatic LNs in the induc-
tion of TGF- production by pDCs. Because we observed 
that iNKT cells secrete some IL-10 and express PD-1 (Fig. 5 D 
and Fig. S6 B), whereas pDCs express high levels of PD-L1 
(Table II) in the pancreatic LN after LCMV infection, we in-
vestigated the role of these molecules in the induction of 
TGF-–producing pDCs by iNKT cells. TGF- secretion 
was abrogated when anti–PD-L1, anti–IL-10R, or both mAbs 
Foxp3-GFP+/+ BDC2.5 C/ NOD mice, were transferred 
into Ins-NP mice that had been infected with LCMV 4 d 
earlier (Fig. S5). 6 d after transfer, GFP+ BDC2.5 T reg cells 
were detected in pancreatic LNs and islets, and, importantly, 
the frequency and absolute number of induced T reg cells 
were increased in -GalCer–treated and V14 mice as com-
pared with control mice (Fig. 4 B). Moreover, the induction 
of GFP+ BDC2.5 T reg cells in pancreatic LNs and islets   
of V14 Ins-NP mice was dependent on pDCs and TGF-, 
as specific depleting or blocking mAb treatments, respec-
tively, abrogated this conversion (Fig. 4 B). In noninfected 
mice, treated or not with -GalCer, very few GFP+ BDC2.5   
T reg cells were detected (unpublished data). To demonstrate 
that pDCs directly induced T reg cells in the pancreatic LNs 
through TGF- secretion, we performed co-culture experi-
ments with sorted pDCs from infected Ins-NP mice (day 6 
after infection) and anti-islet BDC2.5 T cells devoid of   
T reg cells (Fig. 4 C). Only pDCs isolated from the pancreatic 
LNs and not from the spleen of infected mice were able to 
convert GFP+ T reg cells from naive BDC2.5 T cells. Impor-
tantly, the addition of blocking anti–TGF- mAb in the   
co-culture abrogated the induction of T reg cells by pDCs 
isolated from pancreatic LNs. pDCs isolated from pancreatic 
islets did not induce T reg cell conversion (unpublished 
data); however, for technical reasons, these experiments could 
only be performed with twofold less pDCs. In contrast to 
pancreatic LN pDCs, cDCs from this organ and from the 
spleen of infected mice did not induce T reg cell conversion 
(Fig. 4 C). We next addressed whether the proliferation of the 
existing pool of T reg cells could also contribute to the in-
crease of pancreatic islet T reg cell number after viral infec-
tion. 11 d after LCMV challenge, the frequency of proliferating 
Ki67+ T reg cells increased only marginally in the pancreatic 
LNs and pancreas from both control and V14 Ins-NP mice 
compared with uninfected mice (Fig. S5 D). Similar data were 
obtained at day 8 after infection (unpublished data). Thus,   
T reg cell proliferation could play a minor role compared 
with the high rate of conversion observed after infection. 
Altogether, these results support a critical role for TGF-–
producing pDCs in the pancreatic LNs for the conversion 
of naive T cells into anti-islet–specific T reg cells during 
LCMV infection.
Table II.  Phenotype of cDCs and pDCs in pancreatic LNs from LCMV-infected V14 Ins-NP mice
Cell surface marker cDCs (CD11c+120G8) pDCs (CD11c+120G8+)
Day 0 Day 6 Fold change Day 0 Day 6 Fold change
CD80 255 ± 20 462 ± 11a 1.81 204 ± 36 405 ± 18a 1.98
CD86 325 ± 33 543 ± 18a 1.67 285 ± 19 475 ± 31a 1.67
CD40 240 ± 18 470 ± 41a 1.95 125 ± 12 350 ± 20a 2.80
I-Ag7 (MHC class II) 824 ± 45 1,180 ± 37a 1.43 201 ± 43 274 ± 51a 1.36
PD-L1 582 ± 23 1,056 ± 27a 1.81 219 ± 25 738 ± 35a 3.37
MFI was assessed on DC subsets in pancreatic LNs of Ins-NP V14 mice before and 6 d after LCMV infection. Results correspond to means ± SD of values obtained in four 
independent experiments with three pooled mice per group.
aP < 0.05 for day 6 compared with day 0.736 Prevention of T1D during viral infection | Diana et al.
Figure 4.  pDCs produce TGF- in pancreatic LNs that converts naive T cells into T reg cells. (A) CD62L+ CD4+ BDC2.5 T cells were isolated from 
BDC2.5 CD45.2+/+ C/ NOD females, and 106 cells were transferred into Ins-NP mice 4 d after LCMV infection. Cells from pancreatic LNs and islets were 
recovered 6 d after transfer and then restimulated with PMA-ionomycin in the presence of brefeldin A over 4 h and then stained with anti–TCR-, anti-CD4,  
and anti-CD45.2 mAbs and IFN- mAb for intracellular expression. The frequency of gated cells is showed. Data are represented as mean values ± SD 
obtained in three independent experiments, each performed with three pooled mice. *, P < 0.05 compared with control mice. (B) CD62L+ CD4+ GFP 
BDC2.5 T cells were isolated from BDC2.5 CD45.2+/+ Foxp3-GFP+/+ C/ NOD females, and 106 cells were transferred into Ins-NP mice 4 d after infection. 
In some conditions, V14 Ins-NP mice were treated with 120G8 or anti–TGF- mAbs 2 d after infection. Cells from pancreatic LNs and islets were recov-
ered 6 d after transfer and then stained with anti–TCR-, anti-CD4, and anti-CD45.2 mAbs, and GFP expression was analyzed. The frequency and absolute 
number of gated cells are shown. *, P < 0.05 compared with control mice or mAb-treated V14 mice compared with untreated V14 mice. (C) 105 CD62L+ 
CD4+ GFP BDC2.5 T cells were co-cultured with 104 pDCs or cDCs sorted from spleen or pancreatic LNs of infected V14 Ins-NP mice (4 d earlier).  
Cells were cultured for 3 d in complete medium with 25 U/ml recombinant human IL-2 with or without 100 µg/ml anti–TGF- mAb and then stained with 
anti–TCR-, anti-CD4, and anti-CD45.2 mAbs, and GFP expression was analyzed. Data are represented as mean values ± SD obtained in four independent 
experiments. *, P < 0.05 pancreatic LNs compared with spleen or anti–TGF- mAb–treated culture compared with untreated one.JEM VOL. 208, April 11, 2011 
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blocking anti–IL-10R or anti–PD-L1 mAbs decreased both 
the frequency and the MFI of TGF- produced by pDCs in 
pancreatic LNs at day 6 (Fig. 5 F). Collectively, these results 
were included to the culture. No TGF- secretion was detected 
when iNKT cells or pDCs from the spleen or pancreatic LNs 
were cultured alone. Importantly, treating infected mice with 
Figure 5.  Induction of tolerogenic pDCs by iNKT cells requires IL-10 and PD-1–PD-L1 pathways. Analysis of iNKT cell frequency and phenotype 
of LCMV-infected Ins-NP mice. Cells from pancreatic LNs (PLN) and islets were harvested at various times after infection. (A–C) Cells were stained with 
tetramer-CD1d–-GalCer, anti-CD45, anti–TCR-, and anti-CD69 mAbs. *, P < 0.05 compared with day 0. (D) Cells were incubated for 4 h in presence of 
brefeldin A and then stained with tetramer-CD1d–-GalCer, anti-CD45, and anti–TCR- mAbs and then stained with anti–IL-10 mAb for intracellular 
expression. Data are represented as mean values ± SD obtained in two to four independent experiments, each performed with three pooled mice. (E) iNKT 
cells and 105 pDCs were sorted from spleen or pancreatic LNs of infected V14 Ins-NP mice (4 d earlier). Cells were cultured for 90 h in complete medium 
with 10 µg/ml control isotype, anti–PD-L1, anti–IL-10R, or both mAbs. Supernatants were recovered, and TGF- production was analyzed by ELISA. Data 
are represented as mean values ± SD obtained in three independent experiments. *, P < 0.05 compared with isotype control. (F) 6 d after infection, cells 
from pancreatic LNs of Ins-NP mice treated on day 3 with anti–IL-10R or anti–PD-L1 mAbs or control isotype were incubated for 5 h in presence of 
brefeldin A and then stained with anti-CD11c and 120G8 mAbs and then intracellularly with anti–TGF- mAb. Data are representative of three indepen-
dent experiments with three pooled mice per group. *, P < 0.05 compared with untreated mice.738 Prevention of T1D during viral infection | Diana et al.
Figure 6.  iNKT cells prevent T1D in infected Ins2/ NOD mice and promote pancreatic islet T reg cell accumulation. (A and B) T1D incidence in 
Ins2/ mice or Ins2/ Cd1d/ mice, infected or not with 105 PFU LCMV and treated or not with -GalCer at 5 wk of age; in some conditions, mice were 
treated 4 d after infection with 120G8, anti-CD25, or anti–TGF- mAbs or with respective control isotype (n = 10–12 mice per group). (C) Analysis of CD4+ 
Foxp3+ T cells 10 d after LCMV challenge of Ins2/ mice, infected or not with LCMV and treated or not with -GalCer. Spleens and pancreatic LNs and islets 
were harvested, and cells were stained with anti–TCR-, anti-CD4, and anti-Foxp3 mAbs. Data are represented as mean values ± SD obtained in three inde-
pendent experiments with three pooled mice for each group. *, P < 0.05 compared with uninfected and untreated Ins2/ mice.JEM VOL. 208, April 11, 2011 
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-GalCer injection and/or LCMV infection (Fig. 7 A). The 
anti-IGRP206–214 CD8+ T cell response was lower in LCMV-
infected (3.2 ± 2.0%) compared with uninfected mice (8.1 ± 
2.0%). Although -GalCer injection alone had no effect on the 
pancreatic anti-IGRP206–214 response (9.4 ± 2.5%), -GalCer 
injection synergized with LCMV infection to further decrease 
the diabetogenic response (0.8 ± 0.5%). The CD8+ T cell re-
sponse against the viral epitope NP396–404 was also reduced by 
-GalCer treatment in LCMV-infected mice (Fig. 7 A).
To assess the involvement of T reg cells, pDCs, and TGF- 
in this dampening of the diabetogenic T cell responses after 
-GalCer injection and LCMV infection, Ins2/ mice were 
treated with specific mAbs (Fig. 7 B). These treatments abro-
gated the inhibition of the IFN-+ anti-IGRP206–214 CD8+  
T cell response in the pancreatic islets of LCMV-infected/ 
-GalCer–treated Ins2/ mice. Importantly, the frequency 
of anti-IGRP206–214 CD8+ T cells measured by tetramer stain-
ing was similar in LCMV-infected/-GalCer–treated and 
control Ins2/ mice, supporting a local regulation that damp-
ens the effector function of diabetogenic T cells (Fig. 7 C). Col-
lectively, these data show that iNKT cell activation and LCMV 
infection synergize to dampen diabetogenic T cell responses 
in pancreatic islets through pDCs and T reg cells preventing 
spontaneous T1D.
DISCUSSION
Many studies have described that infections, including viral 
infections, can prevent T1D (Lehuen et al., 2010); however, 
the mechanisms remain elusive. This study unveils an impor-
tant new aspect of the protective role of iNKT cells in T1D 
during viral infection. We demonstrate that iNKT cells in-
duce tolerogenic pDCs, which convert naive T cells into T reg 
cells that dampen the diabetogenic T cell responses in the 
pancreatic islets and thereby prevent T1D.
The ability of pDCs to induce T reg cells was previously 
described in a noninfectious context (Ochando et al., 2006; 
Sharma et al., 2007; Hadeiba et al., 2008; Irla et al., 2010; 
Martín-Gayo et al., 2010) and after TLR9 triggering of human 
pDCs (Ito et al., 2007). Some of these studies described a role 
for the IDO and/or the ICOS–ICOS ligand pathways (Ito   
et al., 2007; Sharma et al., 2007). However, these molecules 
did not play a key role in the expansion of pancreatic T reg 
cells  by  pDCs  after  LCMV  infection.  Interestingly,  1-MT 
treatment did partially interfere with the T1D prevention me-
diated by iNKT cells. This could be because this assay is more 
sensitive in revealing some IDO involvement or alternatively 
because IDO is involved at a different level. T reg cells might 
initiate an immunoregulatory pathway involving tryptophan 
catabolism in DCs (Fallarino et al., 2003). Our present study 
highlights the critical role of TGF- in the generation of   
T reg cells because anti–TGF- mAb treatment abrogated 
the increase in T reg cell frequency in the pancreatic islets of 
infected mice. Moreover, a high percentage of pDCs present 
in the pancreatic LNs after LCMV infection produced TGF-. 
In keeping with a role for this cytokine in the generation of 
T reg cells (Kretschmer et al., 2005; Li and Flavell, 2008),   
strongly suggest that, during LCMV infection, iNKT cells in 
pancreatic LNs induce TGF- secretion by pDCs through 
IL-10 signaling and PD-1–PD-L1 interaction.
iNKT cell–pDC cooperation similarly induces T reg cell 
protective function in a spontaneous model of T1D
To extend our results obtained using Ins-NP mice to a spon-
taneous model of T1D, we used Ins2/ NOD mice, which 
develop accelerated T1D (Thébault-Baumont et al., 2003). 
This strain was used in preference to the wild-type NOD as 
it has a rapid onset of T1D, thus facilitating the choice of tim-
ing for LCMV infection, -GalCer treatment, and disease 
follow up. To determine the role of iNKT cells in this model, 
we followed T1D development in Ins2/ mice after LCMV 
infection, -GalCer injection, or a combination of both, all 
performed at 5 wk of age (Fig. 6 A, left). All Ins2/ mice, 
whether  or  not  injected  with  -GalCer,  developed T1D   
before 20 wk, whereas only 50% of LCMV-infected Ins2/ 
mice were diabetic after 25 wk of age. Interestingly, only 10% 
of Ins2/ mice that were both infected and -GalCer treated 
became diabetic at 25 wk, revealing a synergistic protective 
effect of viral infection and iNKT cell stimulation. To further 
determine whether iNKT cells were required for the LCMV-
induced protection against diabetes, Ins2/ Cd1d/ mice 
were infected or not with LCMV (Fig. 6 A, right). T1D de-
velopment  in  these  mice  was  not  prevented  by  infection, 
demonstrating the critical role of iNKT cells in the protec-
tion against spontaneous diabetes after LCMV infection.
To address the putative role of T reg cells in this model, we 
measured their frequency in Ins2/ mice 10 d after infec-
tion, -GalCer treatment, or combined infection and treat-
ment (Fig. 6 C). Although -GalCer treatment alone did not 
impact T reg cell frequency in pancreatic islets, infection alone 
induced some expansion of this cell population. In line with 
the stronger protective effect of combined -GalCer treat-
ment and viral infection, T reg cell frequency in the pancre-
atic islets was further increased when both stimuli were given. 
No difference in T reg cell frequency was observed in lym-
phoid organs. This increased T reg cell frequency in the   
pancreatic islets was still observed 20 wk after infection and 
-GalCer treatment of Ins2/ mice (Fig. S8 A). To further 
analyze the role of T reg cells, pDCs, and TGF- in the pre-
vention of T1D in -GalCer–treated and infected Ins2/ 
mice, treatments with blocking T reg cell, depleting pDCs, 
and blocking anti–TGF- mAbs were performed at the time 
of infection (Fig. 6 B). All of these treatments fully reversed 
the protection against T1D, confirming the critical role of   
T reg cells, pDCs, and TGF- in LCMV-induced T1D pro-
tection. Altogether, these data show that iNKT cell activation 
synergizes with viral infection to expand pancreatic T reg 
cells and prevent T1D in Ins2/ mice in a pDC- and TGF-
–dependent fashion.
To examine the effect of iNKT cells and LCMV infec-
tion on diabetogenic T cell responses, we analyzed the CD8+  
T cell IFN- response against the dominant -cell epitope, 
IGRP206–214, in pancreatic islets of Ins2/ mice 10 d after   740 Prevention of T1D during viral infection | Diana et al.
(Diana et al., 2009). Importantly, blocking this pathway using 
anti-OX40L mAb did not prevent T reg cell expansion in the 
pancreatic islets (Fig. S7 B). Moreover, the role of CD1d was 
also ruled out because there was a similar pancreatic T reg cell 
frequency in mice expressing or not CD1d in the periphery 
(control vs. CD1dpLck Ins-NP mice; Fig. S7 A). Accordingly, 
V14 CD1dpLck and  V14 Ins-NP mice treated with a block-
ing anti-CD1d mAb remained diabetes-free after LCMV   
infection (Fig. S7 C). Our study reveals a new regulatory 
function of iNKT cells in the induction of TGF-–producing 
pDCs through IL-10 secretion and PD-1–PD-L1 inter-
actions. Indeed, co-culture experiments performed with sorted 
cells from infected mice showed that iNKT cells from pan-
creatic LNs incubated with pDCs from spleen or pancreatic 
LNs result in TGF- production, which was abrogated by   
IL-10R and/or PD-L1 blocking mAbs. Furthermore, treating 
infected  mice  with  blocking  anti–IL-10R  or  anti–PD-L1 
mAbs strongly inhibited TGF- production by pDCs in the 
our in vivo and in vitro data clearly demonstrate that in the 
pancreatic LNs, pDCs induce T reg cell conversion from naive 
T cells through TGF- secretion. A similar mechanism has 
been proposed in lupus prevention after injection of a histone 
peptide (Kang et al., 2007). In our study, TGF-–producing 
pDCs are mainly localized in the pancreatic LNs on day 6 after 
LCMV infection. This observation suggests that after their iNKT 
cell–dependent recruitment to the infected islets, activated 
pDCs leave the pancreatic islets to migrate to the pancreatic 
LNs. Our results do not exclude that some pDCs may be re-
cruited from the blood. The importance of draining lymphoid 
tissues in the tolerogenic function of pDCs was recently de-
scribed in the context of cardiac allografts (Ochando et al., 
2006), graft-versus-host disease (Hadeiba et al., 2008), and ex-
perimental autoimmune encephalomyelitis (Irla et al., 2010).
We previously demonstrated that pancreatic iNKT cells 
expressed the OX40 molecule and promoted type I IFN pro-
duction by pDCs through OX40–OX40 ligand interaction 
Figure 7.  iNKT cells dampen the anti-islet CD8+ T cell response in infected Ins2/ NOD mice through pDCs, T reg cells, and TGF-.  
(A–C) Analysis of CD8+ T cells specific for IGRP206–214 (A–C) and NP396–404 (A) in 5-wk-old Ins2/ mice 10 d after LCMV challenge (and treated or not) with 
-GalCer. Pancreatic islets were harvested and cultured for 8 d in complete RPMI medium with recombinant IL-2. Cells were then stimulated for 4 h with 
IGRP206–214 or NP396–404 peptides and stained with anti–TCR-, anti-CD8, and IFN- mAbs. Values correspond to the frequency of epitope-specific CD8+  
T cells in the lymphoid gate. (B) Analysis of IGRP206–214-specific cells among CD8+ T population in pancreatic islets of Ins2/ mice treated with anti-CD25, 
120G8, or anti–TGF- mAbs. (C) For NRP-V7 (high affinity analogue of IGRP206–214 tetramer staining), cells were stained with tetramers (NRP-17 and TUM 
control) and then surface stained with anti-CD8 mAb. Values correspond to the frequency of tetramer-specific CD8+ T cells in the lymphoid gate. Data are 
represented as mean values ± SD obtained in two (B and C) to six (A) independent experiments with three independent mice for each group. *, P < 0.05 
compared with untreated/uninfected Ins2/ mice (A and C) or compared with mAb-untreated mice (B).JEM VOL. 208, April 11, 2011 
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site of immune regulation by T reg cells in spontaneous T1D 
(Chen et al., 2005b; Tang et al., 2008; Feuerer et al., 2009). 
Analysis of effector diabetogenic T cells in pancreatic LNs did 
not show immune regulation in this tissue as there was a simi-
lar frequency of IFN-+ BDC2.5 cells after the transfer of 
naive BCD2.5 T cells into control and V14 infected Ins-NP 
mice. Consistent with the idea of local control of diabeto-
genic responses, CD4+ T cells in the pancreatic islets but not 
in the spleen and pancreatic LNs are activated and produce 
TGF-, and blocking of TGF- at day 9 after infection abol-
ished T1D protection. The key role of TGF- in our study is 
in line with previous studies describing the suppressive mech-
anisms of T reg cells in mouse models of T1D (Green et al., 
2003; You et al., 2006; Filippi et al., 2009).
It is striking that an acute viral infection can induce a 
long-term protection against T1D as observed in the Ins2/ 
mice. Moreover, one single injection of -GalCer strongly 
potentiated this stable protection without affecting the viral 
clearance (Fig. S8 B). Analysis of diabetes-free Ins2/ mice, 
20 wk after combined infection and -GalCer injection, re-
vealed a sustained high frequency of T reg cells in the pancre-
atic islets. This observation suggests that pancreatic T reg cells 
might mediate this long-term tolerance. Because TGF- is 
critical for the maintenance of the T reg cell pool, TGF- 
produced by T reg cells might act in an autocrine manner 
(Li and Flavell, 2008). However, we did not detect TGF- by 
intracellular staining in T reg cells at these later time points 
(unpublished data). Alternatively, the local suppressive envi-
ronment could be sustained by the production of other regu-
latory cytokines and/or by other regulatory cells (Belkaid and 
Oldenhove,  2008;  Belkaid  and Tarbell,  2009).  Importantly, 
upon LCMV infection, T reg cells controlled both antivirus- 
and anti-islet–specific T cell responses. These data fit with the 
emerging concept that multiple T reg cell functions act either 
directly or indirectly at the site of inflammation to create a 
regulatory milieu that promotes bystander suppression (Tang 
and Bluestone, 2008). Even though LCMV infection in the 
absence of -GalCer treatment reduced anti-islet T cell re-
sponses and prevented T1D development in Ins2/ mice, 
there was only a weak increase in T reg cells in the pancre-
atic islets. This moderate expansion of T reg cells might be 
caused by the already high frequency of T reg cells in the 
pancreatic islets of these mice.
We have recently reported that upon LCMV infection, 
iNKT cells and pDCs cooperate to induce an efficient innate 
antiviral type I interferon response (Diana et al., 2009). We 
now describe that both cell types also cooperate to control 
the adaptive immune response in the pancreatic islets through 
the conversion of naive T cells into T reg cells. Thus, iNKT 
cells and pDCs prevent deleterious inflammation subsequent 
to viral infection of the pancreatic islets through two different 
and complementary mechanisms. In contrast, in the spleen, 
iNKT cells promoted antiviral adaptive immune responses, 
which are critical for LCMV clearance (Barber et al., 2006). 
Our data highlight the ambivalent role of iNKT cells depend-
ing on their localization and their interaction with various DC 
pancreatic LNs. Of note, in pancreatic LNs, LCMV infection 
induces IL-10 production and up-regulation of PD-1 on iNKT 
cells as well as PD-L1 up-regulation on pDCs. Interestingly, 
blocking IL-10R in vivo abolished the prevention of LCMV-
induced diabetes by iNKT cells (unpublished data). Our data 
are reminiscent of previous studies suggesting that PD-L1   
ligation results in reverse signaling into the DC, thus inhibit-
ing subsequent immune response (Kuipers et al., 2006; Keir   
et al., 2008). Regarding IL-10, many studies have shown that   
this  cytokine  induced  regulatory  DC  functions  (Li  and   
Flavell, 2008). Moreover a direct role of PD-L1+ pDCs on   
T reg cell generation cannot be ruled out because PD-L1 can 
potentiate and support Foxp3+ T reg cell function and induce 
Foxp3 expression (Francisco et al., 2009). A previous study 
described  the  synergic  role  of  these  regulatory  pathways 
during the anti-LCMV CD8+ T cell response, as a combination 
of blocking mAbs against IL-10R and PD-L1 enhanced the 
viral clearance in C56BL/6 mice (Brooks et al., 2008). Our 
previous (Diana et al., 2009) and present data strengthen the 
role of iNKT cells in promoting dual pDC functions (anti-
viral and tolerogenic), controlling deleterious immune response 
in the pancreatic islets during viral infection.
Our study shows that conversion of naive CD4 T cells 
into T reg cells takes place in pancreatic LNs based on several 
in vivo and in vitro experiments. However, T reg cells mainly 
accumulate in pancreatic islets. These data suggest that after 
their conversion in pancreatic LNs, T reg cells migrate to the 
pancreatic islets where they harbor a fully activated pheno-
type and produce TGF-. Their migration into the inflamed 
tissue  is  reminiscent  of  that  described  in  previous  studies 
(Belkaid and Tarbell, 2009). Therefore, it might not be surpris-
ing that T reg cells do not accumulate in pancreatic LNs and 
could only be detected with sufficient sensitivity after the 
transfer of Foxp3-GFP–negative BDC2.5 T cells. Our data are 
also in agreement with a recent study on experimental auto-
immune encephalomyelitis (Irla et al., 2010). The induction of 
T reg cells in the draining LNs does not lead to an increase of   
T reg cell frequency in this lymphoid tissue, and the authors 
proposed that induced T reg cells migrate from the secondary 
lymphoid tissues to the target tissue. We observed a lower 
Foxp3 expression in T reg cells in the pancreatic islets as com-
pared with lymphoid tissues. This might be related to a later 
differentiation stage of pancreatic T reg cells, as they exhibit a 
more activated phenotype (CD103, CTLA-4, and TGF-).
The involvement of T reg cells in iNKT cell–mediated 
prevention of T1D upon LCMV infection was first suggested 
by the absence of islet destruction despite the high frequency 
of anti-NP396–404 CD8+ T cells in the pancreatic islets of V14   
and -GalCer–treated Ins-NP mice. Similarly, protected 
Ins2/ mice exhibit the same frequency of pancreatic anti-
islet T cells as control Ins2/ mice. Moreover, blockade of   
T reg cell function restored a high frequency of IFN-+ dia-
betogenic CD8+ T cells in the pancreatic islets and subse-
quent T1D in Ins-NP and Ins2/ mice. This local control of 
islet inflammation by iNKT and T reg cells is reminiscent of 
previous studies showing that pancreatic islets are the major 742 Prevention of T1D during viral infection | Diana et al.
Flow cytometry. Cell suspensions were prepared from spleen and pancre-
atic LNs and islets. Cells were stained at 4°C in PBS containing 2% FCS and 
1% EDTA after blocking Fc-R with 2.4G2 mAb. Surface staining was per-
formed with antibodies all from BD except 120G8 and anti–TGF- (2G7) 
mAbs, which were FITC-conjugated in our laboratory. For CD1d tetramer 
preparation, biotinylated soluble CD1d was loaded with -GalCer and then 
incubated  with  allophycocyanin-conjugated  streptavidin.  H2Db-NP396–404 
dextramers were purchased from Dako.  To detect degranulation, anti-CD107a 
mAb (1D4B; BD) was added during restimulation with NP396–404 peptide 
(from J.-P. Briand, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, 
France). For IFN- (XMG1.2; BD) intracellular staining, single-cell suspen-
sions were stimulated with 1 µg/ml of viral NP396–404 peptide for 5 h at 37°C 
in the presence of 10 U/ml recombinant mouse IL-2 (R&D Systems) and   
1 µg/ml brefeldin A. For IL-10 (BD) and TGF- (2G7) intracellular staining 
of CD4+ T cells, single-cell suspensions were incubated with PMA, ionomy-
cin, and brefeldin A (all from Sigma-Aldrich) for 5 h at 37°C (Kared et al., 
2005). TGF- (2G7) intracellular staining of pDCs was performed after a 5-h 
incubation in the presence of brefeldin A without exogenous stimulation. 
Validation for this assay was performed using an isotype control and staining 
after blocking the 2G7 mAb with recombinant human TGF- (R&D Sys-
tems). T reg cells were detected using the anti–mouse/rat Foxp3 staining set 
(FJK-16s; eBioscience). T reg cell proliferation was assessed using an anti– 
human Ki67 staining kit (BD) containing anti-Ki67 (B56). Foxp3 staining 
was performed before anti-Ki67 staining. For NRP-V7 tetramer (from the 
National Institutes of Health tetramer core facility) staining, cells were incu-
bated for 30 min at 37°C in Lck inhibitor buffer (50 nM PBS–2% FBS; 
EMD) and then stained with tetramers for 45 min at room temperature in 
Lck inhibitor buffer followed by surface staining with anti-CD8 mAb for   
15 min at 4°C. Stained cells were analyzed on a FACS Aria flow cytometer 
equipped with 488-, 605-, and 405-nm lasers (BD).
Preparation  of  pancreatic  islets. Mice were sacrificed, and pancreata 
were perfused with 3 ml of a solution containing 1.5 mg/ml collagenase P 
(Roche) and then dissected free from surrounding tissues. Pancreata were 
then digested at 37°C for 10 min. Digestion was stopped by adding PBS–5% 
FCS followed by extensive washes. Islets were then purified on a Ficoll gradi-
ent, picked with a glass pipette, and disrupted by adding 1 ml of cell dissocia-
tion buffer (Invitrogen) for 10 min at 37°C. After another wash, cells were 
resuspended, counted, and used. To measure anti-IGRP206–214 and anti-NP396–404 
CD8+ T cell responses in Ins2/ mice, pancreatic islets were recovered by 
handpicking under a polarized microscope (M3B; Wild Heerbrugg) without 
any prior density separation. Islets were then cultured for 8 d in RPMI me-
dium containing 10% FBS, 1% penicillin/streptomycin, and 25 U/ml recombi-
nant human IL-2 (R&D Systems). For IFN- intracellular staining, single-cell 
suspensions were stimulated for 5 h on resting splenocytes previously pulsed 
with 1 µg/ml peptide in the presence of 1 µg/ml brefeldin A.
Adoptive transfer experiment. CD62L+ CD4+ GFP BDC2.5 T cells 
were isolated from CD45.2+/+ Foxp3-GFP+/+ BDC2.5 C/ NOD females. 
Splenocytes were enriched in T cells by negative selection (Dynal beads;   
Invitrogen) and then FACS sorted as CD62L+ CD4+ GFP cells. These cells 
were injected i.v. (106 cells/mouse) into Ins-NP mice females LCMV in-
fected 4 d earlier. The same procedure was used for isolation of CD62L+ 
CD4+ BDC2.5 T cells from CD45.2+/+ BDC2.5 C/ NOD females.
In vitro cultures. 105 CD62L+ CD4+ GFP BDC2.5 T cells sorted from 
BDC2.5 CD45.2+/+ C/ NOD females were co-cultured with 104 pDCs 
sorted from spleen or pancreatic LNs of infected V14 Ins-NP mice (4 d 
earlier). Cells were cultured for 3 d in complete medium with 25 U/ml re-
combinant human IL-2 and 10 ng/ml peptide 1040-51, a mimotope of BDC2.5 
T cells (Judkowski et al., 2001), with or without 100 µg/ml anti–TGF- 
mAb and then stained with anti–TCR-, anti-CD4, and anti-CD45.2 mAbs, 
and GFP expression was analyzed.
105 sorted cells (iNKT cells and pDCs) from pancreatic LNs or spleen of 
4-d-infected Ins-NP V14 female mice were cultured in X-Vivo 15 serum-free 
subsets (Lehuen et al., 2010). Upon LCMV infection, iNKT 
cells promote CD8+ T cell response in the spleen by inter-
acting with cDCs producing IL-12 (Diana et al., 2009; un-
published data), whereas in the pancreatic islets and LNs, iNKT 
cells activate pDCs to produce type I IFN and TGF-, re-
spectively. iNKT cells exert these various functions through 
distinct molecular pathways, which must be tightly regulated. 
The stimulation of adaptive immune responses by iNKT cells 
has also been observed after parasitic and bacterial infections, 
in which iNKT cells cooperate with cDCs (Tupin et al., 2007). 
Interestingly, these infectious agents can also prevent T1D de-
velopment (Alyanakian et al., 2006; Zaccone et al., 2008), and 
it would be interesting to further explore the involvement of 
iNKT cells in the protective role of these infections.
Our findings on the regulatory role of iNKT cells might 
have broad implications in human diseases, given the marked   
inter-individual  differences  in  human  iNKT  cell  frequencies 
(Lee et al., 2002) and the putative role of infections in many auto-
immune disorders (von Herrath et al., 2003). Even though some 
controversy exists regarding the frequency of blood iNKT cells 
in diabetic patients (Wilson et al., 1998; Lee et al., 2002), only 
limited analysis of pancreatic LN iNKT cells has been performed 
so far (Kent et al., 2005). Our study suggests that it may be im-
portant to carry out such an analysis because iNKT cells appear 
to act locally in the pancreatic LNs to protect against  T1D. Finally, 
this study, using both a well-defined model of virus-induced 
T1D and a spontaneous model of T1D, reveals new regulatory 
mechanisms  by  which  iNKT  cells  and  pDCs  prevent  auto-
immune diseases during viral infection. These data pave the way 
to design new clinical approaches combining the manipulation 
of iNKT cells and pDCs by specific agonists.
MATERIALS AND METHODS
Mice and treatments. The V14 transgenic NOD mouse line expressing the 
V14-J18 TCR  chain corresponds to line A14-86 (Beaudoin et al., 2002). 
The Ins-NP NOD, Cd1d/NOD, Cd1dpLck NOD, and Ins2/ NOD mice 
were previously described (Thébault-Baumont et al., 2003; Martinic et al., 2007; 
Novak et al., 2007a).  V14, Cd1d/ NOD mice were crossed to Ins-NP NOD 
mice. Foxp3-GFP+/+ mice (Fontenot et al., 2005) were backcrossed >10 times 
on a NOD background (from D. Mathis and C. Benoist, Harvard Medical   
School, Boston, MA). BDC2.5 CD45.2+/+ Foxp3-GFP+/+ C/ NOD mice 
were generated by backcrossing to BDC2.5 CD45.2+/+ C/ NOD mice. 
Mice were bred and housed in specific pathogen-free conditions and used at 6–8 
wk of age. In some experiments, mice were injected i.p. with 2 µg/mouse   
-GalCer (from the Kirin Brewery) on the day of infection (day 0), with 1 mg/
mouse depleting 120G8 mAb (from the Schering-Plough Research Institute) or 
anti-CD62L mAbs on days 4 and 6, with 0.5 mg/mouse of blocking anti-CD25 
(PC61) or anti–TGF- (2G7) on days 3, 6, and 9, or only at day 9, or with   
0.25 mg/mouse blocking anti–IL-10R (1B1) or anti–PD-L1 (10F.9G2; Bio-
Express) mAbs on day 2 or with respective control isotype, after LCMV infection, 
as mentioned in the figure legend. This study was approved by the local ethics 
committee on animal experimentation (P2.AL.045.08).
Virus. LCMV Armstrong clone 53b stocks were prepared by a single passage 
on baby hamster kidney 21 cells. Mice were infected with a single i.p. dose of 
105 or 104 PFU as indicated.
Diabetes diagnosis. Mice were tested every day for diabetes. Overt diabe-
tes was defined as two positive urine glucose tests, confirmed by a glycemia 
>200 mg/dl. Glukotest and Heamogokotest kits were purchased from Roche.JEM VOL. 208, April 11, 2011 
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medium  (BioWhittaker  and  Cambrex)  and  1%  penicillin/streptomycin.   
In some wells, anti–PD-L1 (MIH5) or anti–IL-10R (1B1) mAbs or control 
isotype (rat anti–mouse IgG) was added to the culture at 10 µg/ml. Culture 
supernatants were collected after 90 h for ELISA analysis. Samples were acid-
ified by addition of HCl 1N for 15 min and neutralized by NaOH 1N, and 
then the amount of TGF-1 was measured by the TGF-1 Emax Immuno-
Assay System (Promega).
T reg cell suppression assay. Splenic CD45.2+ CD4+ CD25 cells labeled 
with CFSE were used as T resp cells. 104 T resp cells were cultured for 72 h 
with anti-CD3/anti-CD28 Dynabeads (Invitrogen; according to the manufac-
turer’s protocol) in the presence or absence of 5 × 103 T reg cells sorted from the 
pancreatic islets of infected Foxp3-GFP–Ins-NP control or V14 mice. The 
division of T resp cells was assessed by flow cytometry by dilution of CFSE.
Statistical analysis. Diabetes incidence was plotted according to the Kaplan-
Meier method. Incidences between groups were compared with the log-rank 
test. For other experiments, comparison between means was performed using 
the nonparametric Mann-Whitney U test. Reported values are means ± SD 
as indicated. P-values <0.05 were considered statistically significant. All data 
were analyzed using Prism version 5 software (GraphPad Software).
Online supplemental material. Fig. S1 shows that iNKT cells alter the 
anti-LCMV CD8+ response in pancreatic islets of  V14 or -GalCer–treated 
Ins-NP mice. Fig. S2 shows the frequency and phenotype of T reg cells in the 
spleen and pancreatic LNs and islets of Ins-NP mice after LCMV infection. 
Fig. S3 shows the kinetics of pDC frequency in the control Ins-NP mice 
during infection, the efficacy of the pDC depletion by 120G8 mAb treat-
ment, and the validation of intracellular TGF- staining. Fig. S4 shows T reg 
frequency and diabetes development in ICOS/ Ins-NP NOD mice or in 
Ins-NP mice after 1-MT treatment. Fig. S5 shows the strategy of sorting   
naive BDC T cells devoid in Foxp3+ T cells and their transfer into Ins-NP 
mice and the frequencies of proliferating Ki67+ T reg cells determined in the 
Foxp3+ CD4+ T cell population. Fig. S6 shows the analysis of iNKT cell 
phenotype and frequency in pancreatic LNs and islets of LCMV-infected 
V14 Ins-NP mice. Fig. S7 shows the analysis of iNKT cell phenotype and 
frequency in pancreatic LNs and islets of LCMV-infected V14 Ins-NP or 
CD1dpLck V14 Ins-NP mice after pDC depletion. Fig. S8 shows the analysis 
of T reg cell frequency in Ins2/ mice 20 wk after LCMV infection and 
-GalCer treatment. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20101692/DC1.
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